(OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform, today announced that it ...
Q4 2026 Earnings Call May 19, 2026 7:30 AM EDTCompany ParticipantsVipul Garg - Senior Vice President of Investor ...
New research by an international team of scientists finds that fully phasing out fossil fuels worldwide by 2050 would require ...
Back in late April, Apr 25, 2026, I wrote about Lockheed Martin CEO Jim Taiclet calling the current defense environment a "golden opportunity." These are two words that don't often come up in earnings ...